The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26

被引:52
|
作者
Varasteh, Zohreh [1 ]
Mitran, Bogdan [1 ]
Rosenstrom, Ulrika [3 ]
Velikyan, Irina [1 ]
Rosestedt, Maria [1 ]
Lindeberg, Gunnar [3 ]
Sorensen, Jens [4 ]
Larhed, Mats [5 ]
Tolmachev, Vladimir [2 ]
Orlova, Anna [1 ]
机构
[1] Uppsala Univ, Fac Pharm, Dept Med Chem, Preclin PET Platform, S-75183 Uppsala, Sweden
[2] Uppsala Univ, Fac Med, Dept Immunol Genet & Pathol, S-75183 Uppsala, Sweden
[3] Uppsala Univ, Fac Pharm, Dept Med Chem, Organ Pharmaceut Chem, S-75183 Uppsala, Sweden
[4] Uppsala Univ, Nucl Med & PET, S-75183 Uppsala, Sweden
[5] Uppsala Univ, Fac Pharm, Dept Med Chem, Sci Life Lab, S-75183 Uppsala, Sweden
基金
瑞典研究理事会;
关键词
Bombesin antagonistic analog; NOTA; DOTA; NODAGA; DOTAGA; Molecular imaging; CONJUGATED BOMBESIN ANTAGONIST; POSITRON-EMISSION-TOMOGRAPHY; PET; EXPRESSION; CONSTANTS; AFFINITY; AGONISTS; BINDING; CANCER; LENGTH;
D O I
10.1016/j.nucmedbio.2014.12.009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Overexpression of gastrin-releasing peptide receptors (GRPR) has been reported in several cancers. Bombesin (BN) analogs are short peptides with a high affinity for GRPR. Different BN analogs were evaluated for radionuclide imaging and therapy of GRPR-expressing tumors. We have previously investigated an antagonistic analog of BN (D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2, RM26) conjugated to NOTA via a PEG(2) spacer (NOTA-PEG(2)-RM26) labeled with Ga-68, In-111 and (AlF)-F-18. Ga-68-labeled NOTA-PEG(2)-RM26 showed high tumor-to-organ ratios. Methods: The influence of different macrocyclic chelators (NOTA, NODAGA, DOTA and DOTAGA) on the targeting properties of Ga-68-labeled PEG(2)-RM26 was studied in vitro and in vivo. Results: All conjugates were labeled with generator-produced Ga-68 with high yields and demonstrated high stability and specific binding to GRPR. The IC50 values of Ga-nat-X-PEG(2)-RM26 (X = NOTA, DOTA, NODAGA, DOTAGA) were 2.3 +/- 0.2, 3.0 +/- 0.3, 2.9 +/- 0.3 and 10.0 +/- 0.6 nM, respectively. The internalization of the conjugates by PC-3 cells was low. However, the DOTA-conjugated analog demonstrated a higher internalization rate compared to other analogs. GRPR-specific uptake was found in receptor-positive normal tissues and PC-3 xenografts for all conjugates. The biodistribution of the conjugates was influenced by the choice of the chelator moiety. Although all radiotracers cleared rapidly from the blood, [Ga-68]Ga-NOTA-PEG(2)-RM26 showed significantly lower uptake in lung, muscle and bone compared to the other analogs. The uptake in tumors (5.40 +/- 1.04 %ID/g at 2 h p.i.) and the tumor-to-organ ratios (25 +/- 3, 157 +/- 23 and 39 +/- 4 for blood, muscle and bone, respectively) were significantly higher for the NOTA-conjugate than the other analogs. Conclusions: Chelators had a clear influence on the biodistribution and targeting properties of Ga-68-labeled antagonistic BN analogs. Positively charged [Ga-68]Ga-NOTA-PEG(2)-RM26 provided a low kidney radioactivity uptake, high affinity, high tumor uptake and high image contrast. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:446 / 454
页数:9
相关论文
共 50 条
  • [41] Effects of 68Ga-labeled PEG and non-PEG variant peptides as HER2-targeting probes on the progression of gastrointestinal (GI) tumor cells
    Ji, Xiang
    Han, Yiting
    Li, Xiang
    Shi, Shiwei
    Yang, Dong
    Cai, Xiaowei
    MOLECULAR & CELLULAR TOXICOLOGY, 2024,
  • [42] GRPR-Targeted Radiotherapy: Influence of Chelator on Labeling and Biodistribution of Four 177Lu-Labeled Analogues of the GRPR-Antagonist PEG2-RM26
    Orlova, A.
    Mitran, B.
    Maina, T.
    Nock, B. A.
    Rinne, S. S.
    Tolmachev, V.
    Rosenstrom, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S295 - S296
  • [43] Evaluation of 68Ga-labeled F56 vascular endothelial growth factor receptor 1 targeting peptide for tumor specific imaging
    Zhang, Qian
    Zhao, Ke
    Yang, Zhi
    Zhu, Hua
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [44] Synthesis and Evaluation of the First 68Ga-Labeled C-Terminal Hydroxamate-Derived Gastrin-Releasing Peptide Receptor-Targeted Tracers for Cancer Imaging with Positron Emission Tomography
    Wang, Lei
    Kuo, Hsiou-Ting
    Chen, Chao-Cheng
    Chapple, Devon
    Colpo, Nadine
    Ng, Pauline
    Lau, Wing Sum
    Jozi, Shireen
    Benard, Francois
    Lin, Kuo-Shyan
    MOLECULES, 2024, 29 (13):
  • [45] Automated Synthesis of 68Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting
    Hoermann, Anton Amadeus
    Plhak, Elisabeth
    Klingler, Maximilian
    Rangger, Christine
    Pfister, Joachim
    Schwach, Gert
    Kvaternik, Herbert
    von Guggenberg, Elisabeth
    MOLECULES, 2022, 27 (06):
  • [46] First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9
    Silvano Gnesin
    Francesco Cicone
    Periklis Mitsakis
    Axel Van der Gucht
    Sébastien Baechler
    Raymond Miralbell
    Valentina Garibotto
    Thomas Zilli
    John O. Prior
    EJNMMI Research, 8
  • [47] First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9
    Gnesin, Silvano
    Cicone, Francesco
    Mitsakis, Periklis
    Van der Gucht, Axel
    Baechler, Sebastien
    Miralbell, Raymond
    Garibotto, Valentina
    Zilli, Thomas
    Prior, John O.
    EJNMMI RESEARCH, 2018, 8
  • [48] Synthesis and evaluation of 68Ga-labeled [Leu13ψThz14] Bombesin(7-14) analogues for imaging gastrin-releasing peptide receptor expression with positron emission tomography
    Wang, Lei
    Zhang, Zhengxing
    Merkens, Helen
    Colpo, Nadine
    Zeisler, Jutta
    Zhang, Chengcheng
    Roxin, Aron
    Tan, Ruiyan
    Benard, Francois
    Lin, Kuo-Shyan
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S219 - S219
  • [49] Dosimetry from the first-in-human study on [68Ga]GaNOTA-PEG 2-RM26-A GRPR antagonist
    Bjareback, A.
    Tzortzakakis, A.
    Estenberg, U.
    Axelsson, R.
    Jonmarker, O.
    Altena, R.
    Li, C.
    Moein, M.
    Orlova, A.
    Tran, T. A.
    Hindorf, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S803 - S803
  • [50] Imaging pancreatic ductal adenocarcinoma using an EphA2 receptor tyrosine kinase binding 68Ga-labeled peptide radiotracer
    Gupta, Kuldeep
    Sharma, Ajay Kumar
    Mishra, Akhilesh
    Chen, Sophia Y.
    Lofland, Gabi
    Armstrong, Todd M.
    Zhang, Lei
    Jaffee, Elizabeth M.
    Nimmagadda, Sridhar
    CANCER RESEARCH, 2022, 82 (12)